Plasma Protease C1-inhibitor Treatment Market is Poised to Garner High Revenues Through Technological Advancements in Plasma Fractionation
C1-inhibitor is a serine protease inhibitor that regulates the activated first component of complement and coagulation cascades. Its deficiency or dysfunction leads to increased vascular …